000			01578nam a2200349Ia 4500
001			265929
003			OCoLC
005			20160527193411.0
008			040504s2004 dcu f000 0 eng c
020			_a0160715121
037			_a552-070-31083-5
040			_aGPO _cGPO
042			_apcc
043			_an-us---
049			_aPUXA _bev
074			_a1027-A
074			_a1027-B (MF)
086	0		_aY 4.V 64/3:108-4
088			_aSerial no. 108-4 (United States. Congress. House. Committee on Veterans' Affairs)
092	0		_a344.04233 _bO966 _222
110	1		_aUnited States _bCongress. _bHouse. _bCommittee on Veterans' Affairs. _bSubcommittee on Health. _2Local _9182913
245	1	0	_aOversight hearing on the availability and eligibility for pharmaceutical services provided by the Department of Veterans Affairs _bhearing before the Subcommittee on Health of the Committee on Veterans' Affairs, House of Representatives, One Hundred Eight [sic] Congress, first session, March 19, 2003.
260			_aWashington _bU.S. G.P.O. _bFor sale by the Supt. of Docs., U.S. G.P.O. _c2004.
300			_aiv, 102 p. _c24 cm.
500			_a"Printed for the use of the Committee on Veterans' Affairs."
500			_aShipping list no.: 2004-0154-P.
500			_aDistributed to some depository libraries in microfiche.
500			_a"Serial no. 108-4."
610	1	0	_aUnited States _bDept. of Veterans Affairs. _bPharmacy Service. _2Local _9182913
650		0	_aPharmaceutical policy _zUnited States. _2Local _9150477
650		0	_aVeterans _xMedical care _zUnited States. _2Local _9185252
999			_c191758 _d191758